Risk Evaluation and Mitigation Strategy (REMS): FDA Perspective on What Physicians Need to Know

2015 
For some drugs, risk mitigation measures beyond FDA-approved labeling are deemed necessary. Learn more about these Risk Evaluation and Mitigation Strategies (REMS).
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    0
    References
    2
    Citations
    NaN
    KQI
    []